Fate Therapeutics, Inc. (FATE)
1.485
-0.14
(-8.33%)
USD |
NASDAQ |
Feb 25, 16:00
1.46
-0.02
(-1.68%)
After-Hours: 20:00
Fate Therapeutics Cash and Short Term Investments (Quarterly) : 215.42M for Sept. 30, 2025
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| MannKind Corp. | 260.04M |
| Vertex Pharmaceuticals, Inc. | 6.611B |
| Ardelyx, Inc. | 264.69M |
| ACADIA Pharmaceuticals, Inc. | 847.02M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |